Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Acanthosis nigricans
ADR ID BADD_A00043
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.32      Neoplasm related morbidities
16.32.01      Paraneoplastic syndromes NEC
16.32.01.003      Acanthosis nigricans
23      Skin and subcutaneous tissue disorders
23.01      Cornification and dystrophic skin disorders
23.01.04      Skin hyperplasias and hypertrophies
23.01.04.001      Acanthosis nigricans
Description A circumscribed melanosis consisting of a brown-pigmented, velvety verrucosity or fine papillomatosis appearing in the axillae and other body folds. It occurs in association with endocrine disorders, underlying malignancy, administration of certain drugs, or as in inherited disorder. [MeSH]
MedDRA Code 10000350
MeSH ID D000052
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Acanthosis nigricans | Acquired acanthosis nigricans | Acanthosis Nigricans | Acanthosis Nigrican | Nigrican, Acanthosis | Nigricans, Acanthosis
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00623Dexamethasone0.000687%
BADD_D00809Escitalopram0.000095%
BADD_D01009Gemcitabine0.000799%
BADD_D01563Nicotinate--
BADD_D02522Lithium citrate-
The 1th Page    1    Total 1 Pages